FDA Approved: NELARABINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for Nelarabine by Zydus Lifesciences Limited under ANDA 215037. This action updates the regulatory status of this produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Acute Lymphoblastic Leukemia
• T-cell Lymphoblastic Lymphoma

Drugs mentioned

• Nelarabine (Nelarabine)

Snippet

SUPPL AP for NELARABINE (NELARABINE)